Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?

Overview of attention for article published in Respiratory Research, October 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 75 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,528 followers.

@NICEComms @ERSpublications @LondonAsthma Tezepelumab is a mAb targeting the alarmin TSLP, which is released by epithelial cells in response to pro-inflammatory stimuli. It sits higher up the inflammatory cascade than IL-5, IL-4 & IL-13 so blocking it

03 Sep 2022

Reply Repost Favourite

Unmet need in severe, uncontrolled #asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option? https://t.co/BjweQdRNGy

20 Oct 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.